Peru: Digemid arranges the recall of products with valsartan after warning about possible carcinogenic impurity
Murilo Freitas - 16:43, 13 de July de 20181,104
0
104 lots of 33 products were immobilized for patients with high blood pressure.
The Directorate General of Medicines, Supplies and Drugs (Digemid), of the Ministry of Health (Minsa), ordered the withdrawal of 33 products containing valsartan (active ingredient used for arterial hypertension) in response to alerts issued by the European Medicines (EMA) and the Spanish Agency for Medicines and Health Products (AEMPS), which warned of having found a probably carcinogenic impurity.
